Vijaya Diagnostic Centre (BOM:543350) EBIT: ₹2,659 Mil (TTM As of Mar. 2026)


BOM:543350 Vijaya Diagnostic Centre Ltd BOM:543350
82 GF Score
Price ₹1,368.00
GF Value ₹1,181.73
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Vijaya Diagnostic Centre EBIT?

Vijaya Diagnostic Centre BOM:543350 +0.93% 82 EBIT is ₹2,659 Mil as of Mar. 2026. GuruFocus rates BOM:543350 with a GF Score™ of 82/100 and a GF Value™ of ₹1,181.73 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Vijaya Diagnostic Centre's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₹736 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2,659 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Vijaya Diagnostic Centre's annualized ROC % for the quarter that ended in Mar. 2026 was 16.72%. Vijaya Diagnostic Centre's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 30.54%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Vijaya Diagnostic Centre's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 1.87%.

Vijaya Diagnostic Centre  (BOM:543350) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Vijaya Diagnostic Centre's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=2847.668 * ( 1 - 25.42% )/( (0 + 12705.08)/ 1 )
=2123.7907944/12705.08
=16.72 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0 - 0 - ( 0 - max(0, 0 - 0+0))
=0

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=15070.483 - 385.051 - ( 2891.253 - max(0, 1238.644 - 3218.996+2891.253))
=12705.08

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Vijaya Diagnostic Centre's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2943.68/( ( (0 + max(0, 0)) + (9639.169 + max(-685.328, 0)) )/ 1 )
=2943.68/( ( 0 + 9639.169 )/ 1 )
=2943.68/9639.169
=30.54 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(208.602 + 48.92 + 70.221) - (385.051 + 0 + 628.02)
=-685.328

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Vijaya Diagnostic Centre's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=2659.098/142097.321
=1.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vijaya Diagnostic Centre EBIT Related Terms

Vijaya Diagnostic Centre EBIT Historical Data

* Premium members only.

The historical data trend for Vijaya Diagnostic Centre's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vijaya Diagnostic Centre EBIT Chart

Vijaya Diagnostic Centre Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial 1,625.99 1,329.35 1,806.43 2,199.08 2,659.10

Vijaya Diagnostic Centre Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 545.62 596.92 658.09 668.17 735.92

BOM:543350 vs TMO, DHR, IDXX: EBIT Comparison

For the Diagnostics & Research subindustry, Vijaya Diagnostic Centre's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vijaya Diagnostic Centre EV-to-EBIT vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Vijaya Diagnostic Centre's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Vijaya Diagnostic Centre's EV-to-EBIT falls into.


BOM:543350
82GF Score
Vijaya Diagnostic Centre Ltd BOM:543350
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vijaya Diagnostic Centre EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,659 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹2,659 Mil mean?
Vijaya Diagnostic Centre (BOM:543350) has a EBIT of ₹2,659 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Vijaya Diagnostic Centre.
Is Vijaya Diagnostic Centre's EBIT too high?
Vijaya Diagnostic Centre's current EBIT is ₹2,659 Mil. Overall, Vijaya Diagnostic Centre has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vijaya Diagnostic Centre's EBIT compare to TMO and DHR?
Vijaya Diagnostic Centre's EBIT of ₹2,659 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Diagnostics & Research company?
A good EBIT depends on the Medical Diagnostics & Research industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Vijaya Diagnostic Centre. Vijaya Diagnostic Centre's current EBIT is ₹2,659 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vijaya Diagnostic Centre stock overvalued right now?
Based on GuruFocus' analysis, Vijaya Diagnostic Centre (BOM:543350) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,181.73, compared to a current price of ₹1,368.00 — trading 15.8% above its estimated fair value. The current EBIT is ₹2,659 Mil. Vijaya Diagnostic Centre's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Vijaya Diagnostic Centre (BOM:543350), the current EBIT is ₹2,659 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vijaya Diagnostic Centre (BOM:543350) Overvalued in 2026?

Based on GuruFocus' analysis, Vijaya Diagnostic Centre stock appears to be overvalued. The current stock price of ₹1,368.00 is trading 15.8% above its estimated GF Value™ of ₹1,181.73. GuruFocus considers Vijaya Diagnostic Centre to be Modestly Overvalued.

Key valuation signals for BOM:543350:

  • EBIT: ₹2,659 Mil
  • GF Value™: ₹1,181.73 vs. price of ₹1,368.00 (15.8% above fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the BOM:543350 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vijaya Diagnostic Centre Business Description

Other Exchanges VIJAYA:India
Address Ground Floor, FPAI Building, No 6-3-883 Floor, Punjagutta Officers Colony, Near Topaz Building, Hyderabad, TG, IND, 500 082
Vijaya Diagnostic Centre Ltd operates a diagnostic chain in Southern India. The company offers a one-stop solution for pathology and radiology testing services. It provides routine tests, specialized pathology tests, basic tests, and radiology tests. The company also offers a broad spectrum of customized health and wellness packages to its customers. The company's revenue comes from many diagnostic centers, where high-volume sales drive its earnings. The Company operates within India. The company's operations fall within a single business segment, which is Diagnostic Services.
82GF Score

Get the complete analysis for BOM:543350

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,368.00
Price
₹1,181.73
GF Value